IPS Research has conducted over 500 Phase I-IV trials in a wide range of indications, including all of those listed below.

  • ADHD (all ages)
  • Allergy
  • Alzheimer’s disease
  • Anxiety Disorders (all ages) – GAD, Panic, PTSD, OCD
  • Asthma (all ages)
  • Bipolar Disorder (Including all ages and subtypes)
  • Cardiovascular Disorders
  • COPD
  • Depressive disorders (all ages)
  • Diabetes
  • Diabetic Neuropathy
  • Erectile Dysfunction
  • Gastrointestinal disorders
  • Insomnia (all ages)
  • Major Depression (Including all ages and subtypes)
  • Migraine
  • Ophthalmologic disorders
  • Opioid-Induced Constipation
  • Pain management
  • Schizophrenia/Schizoaffective Disorder
  • Sleep Medicine
  • Vaccines
  • Women’s Health